Showing results (61-70 of 408) with videos related to

Sort By:
Pageof 41
American Journal of Hematology|January 2, 2023
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experienceKaran L Chohan, Jonas Paludo, Nishanth Vallumsetla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapyMyron S Czuczman, Christos Emmanouilides, Mohamed Darif, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always InfectionGordon J Ruan, Sangeetha Gandhi, Jithma P Abeykoon, et al.
American Journal of Hematology|December 4, 2008
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphomaStephen M Ansell, Anne J Novak, Steven Ziesmer, et al.
Shock (Augusta, Ga.)|December 30, 2020
A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated CoagulopathyJulie Goswami, Taleen A MacArthur, Meera Sridharan, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 11, 2022
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone LymphomaMuhamad Alhaj Moustafa, Jennifer Peterson, Bradford S Hoppe, et al.
Journal of Medical Ethics|January 2, 2020
Medically assisted gender affirmation: when children and parents disagreeSamuel Dubin, Megan Lane, Shane Morrison, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2008
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitisMark Topazian, Thomas E Witzig, Thomas C Smyrk, et al.
Pageof 41